BERLIN, March 24, 2026 /PRNewswire/ -- BIOTRONIK today announced the initiation of its global pivotal study evaluating the LivIQ leadless pacemaker system. This next-generation single‑device solution ...
Biotronik, the German medical device company, announced the U.S. approval of a new ICD on Monday, that it described as a “game-changer.” 0 0 1 599 3419 UBM Canon 28 8 4010 14.0 Normal 0 false false ...
BIOTRONIK ProMRI ® pacing system portfolio gives patients more access to MRI scanning and physicians more options with single and dual chamber pacemaker systems BERLIN & NICE, France--(BUSINESS WIRE)- ...
BIOTRONIK’s Iperia Series of ICDs and Leads Allow Broadest Range of Patient Access to MRI Diagnostic Options LAKE OSWEGO, Ore., BIOTRONIK, a leading manufacturer of cardiovascular medical technology, ...
Hosted on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
BIOTRONIK has commenced its global pivotal trial assessing the LivIQ leadless pacemaker system, a next-generation single device solution intended for delivering atrioventricular (AV) synchrony through ...
International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results